Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
![]() |
|||||
GSE237039 |
TRIM27 mediates protective immunity against tuberculosis by activating host autophagy flux
|
|
2 | lu z | Jul 03, 2024 | |||
GSE270925 |
Many ETS family transcription factors can recruit mutant p53, and interaction specificity patterns correlate with ETS gene expression changes in ovarian cancer
|
|
2 | Stephanie Metcalf | Jun 28, 2024 | |||
GSE180483 |
PHF6 cooperates with SWI/SNF complexes to facilitate transcriptional progression [ChIP-seq]
|
|
88 |
|
Jacquelyn A Myers | Jun 07, 2024 | ||
GSE228074 |
The epigenetic regulatory role of KDM1A in HCC cells [HepG2_shKDM1A_CUTTag_seq]
|
|
11 |
|
Boshi Wang | May 31, 2024 | ||
GSE260781 |
Effect of VGLL2-NCOA2, YAP5SA and GFP overexpression on chromatin accessibility profiling in HEK293T cells (ATAC-Seq)
|
|
6 | Susu Guo | May 22, 2024 | |||
GSE260782 |
VGLL2-NCOA2 and TEAD1-NCOA2 fusions recruited p300 to drive TEAD-dependent transcription (CUT&RUN)
|
|
12 | Susu Guo | May 22, 2024 | |||
GSE264544 |
Activation of MEK‐ERK‐c‐MYC signaling pathway promotes splenic M2 macrophage polarization to inhibit PHcH-liver cirrhosis
|
|
4 | wang gui hu | Apr 27, 2024 | |||
GSE218390 |
RAS Pathway–Mutated Chronic Myelomonocytic Leukemia at the Single Cell Level
|
|
47 |
|
Feiyang Ma | Apr 21, 2024 | ||
GSE210736 |
Chronic hypoxia remodels the tumor microenvironment to support glioma stem cell growth [scRNAseq+Multiome]
|
|
39 | James Nicholson | Apr 03, 2024 | |||
GSE221263 |
HOTAIR promotes prostate cancer progression by mediating the interaction between Pol2S2 and CDK9 to maintain transcriptional elongation
|
|
31 |
|
Yuyang Qian | Mar 26, 2024 | ||
GSE217406 |
IFRD1 promotes tumor cells “low-cost” survival under glutamine starvation via inhibiting histone H1.0 nucleophagy
|
|
8 |
|
sun xuedan | Mar 23, 2024 | ||
GSE213408 |
ATAC-seq of N and P hiPSCs
|
|
4 | Juli Liu | Mar 13, 2024 | |||
GSE243772 |
Identification and targeting of extremely high-risk gamma delta T-ALL in children [HiChIP, ChIP and ATAC]
|
|
62 | QINGSONG GAO | Mar 01, 2024 | |||
GSE243776 |
Identification and targeting of extremely high-risk gamma delta T-ALL in children
|
|
69 | QINGSONG GAO | Mar 01, 2024 | |||
GSE256192 |
Transcriptome and chromatin accessibility in oral squamous carcinoma with human plasma-like medium culture (ATAC-Seq)
|
|
4 | Jun Nakayama | Feb 21, 2024 | |||
GSE246057 |
Preclinical Optimization of the PI3K/Akt inhibitor Paxalisib for the Treatment of Diffuse Midline Glioma [ATAC-Seq]
|
|
6 | Dylan Kiltschewskij | Feb 20, 2024 | |||
GSE227976 |
Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma
|
|
11 |
|
Lixin Rui | Feb 19, 2024 | ||
GSE223370 |
G-quadruplex DNA structure is a positive regulator of MYC transcription
|
|
|
243 | Larry Melidis | Feb 06, 2024 | ||
GSE205212 |
Notch3 ChIP-sequencing of brain mural cells differentiated from human pluripotent stem cell-derived neural crest via Notch3 activation
|
|
12 |
|
Benjamin D Gastfriend | Feb 02, 2024 | ||
GSE254913 |
Pharmacologic targeting of SUMOylation drives mitochondrial dysfunction and metabolic alterations in B cell Malignancies
|
|
24 | Alexey Danilov | Feb 02, 2024 |